Related Experiment Video
Updated: May 15, 2025

Real-Time Void Spot Assay
Published on: February 10, 2023
Association between novel inflammatory markers and overactive bladder: a cross-sectional study of NHANES 2009 to 2018
Liangwei Wan1,2, Zhipeng Wang1,2, Lei Zhang1,2
1Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Introduction:
To investigate the relationship between Overactive Bladder (OAB) and inflammatory markers, including the Systemic Immune-Inflammation Index (SII), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Inflammation Response Index (SIRI).
Methods:
This cross-sectional study drew upon data from the National Health and Nutrition Examination Survey (NHANES) spanning the 2009-2018 cycles, including 19,194 participants, with OAB identified using the Overactive Bladder Symptom Score (OABSS) based on survey responses. Multivariate logistic regression and restricted cubic spline (RCS) analyses were employed to evaluate the association between these markers and OAB. Subgroup analysis is used to identify potential influencing factors and ensure the robustness of the study results.
Results:
Multivariate logistic regression analysis indicated notable positive correlations between OAB and SII (Q4 OR = 1.25, 95% CI: 1.06-1.46), NLR (Q4 OR = 1.29, 95% CI: 1.12-1.49), and SIRI (Q4 OR = 1.23, 95% CI: 1.05-1.43), with no significance for PLR. Trend tests showed statistical significance for SII, NLR, and SIRI, but not for PLR. RCS analysis also showed a nonlinear relationship among SII, NLR, SIRI, and OAB. It is noteworthy that age is a key influencing factor in the subgroup analysis. These findings suggest that systemic inflammation may play a crucial role in OAB pathophysiology, and inflammatory markers like SII, NLR, and SIRI could serve as potential indicators for identifying individuals at higher risk of OAB, thereby informing early intervention strategies.
Conclusion:
SII, NLR, and SIRI are positively associated with OAB, suggesting a potential role of inflammation in its pathogenesis. However, further validation through prospective cohort studies is needed to establish their clinical utility and causal relationship with OAB.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

